APO Research
Talk to an analyst

APO RESEARCH · REPORT

Therapeutic Proteins and Oral Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Therapeutic Proteins and Oral Vaccines Industry Growth and Trends Forecast to 2032

29 December 2025110 pages

Choose your research edition.

Industry ResearchTherapeutic Proteins and Oral Vaccines Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Therapeutic Proteins and Oral Vaccines Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Therapeutic Proteins and Oral Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Therapeutic Proteins and Oral Vaccines Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Therapeutic Proteins and Oral Vaccines Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

According to APO Research, the global Therapeutic Proteins and Oral Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Therapeutic Proteins and Oral Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Therapeutic Proteins and Oral Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Therapeutic Proteins and Oral Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Therapeutic Proteins and Oral Vaccines market include Abbott, Sanofi, Merck, Roche, Pfizer, Amgen, TransAlgae, Serum Institute of India and Novo Nordisk, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Therapeutic Proteins and Oral Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Therapeutic Proteins and Oral Vaccines market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Therapeutic Proteins and Oral Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Therapeutic Proteins and Oral Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Therapeutic Proteins and Oral Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Therapeutic Proteins and Oral Vaccines Market by Company

Abbott

Sanofi

Merck

Roche

Pfizer

Amgen

TransAlgae

Serum Institute of India

Novo Nordisk

MigVax

Lumen Bioscience

Johnson and Johnson

Emergent Biosolutions

Eli Lilly and Company

Biogen

Therapeutic Proteins and Oral Vaccines Segment by Type

Therapeutic Proteins

Oral Vaccines

Therapeutic Proteins and Oral Vaccines Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Therapeutic Proteins and Oral Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Proteins and Oral Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Proteins and Oral Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Proteins and Oral Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Therapeutic Proteins and Oral Vaccines companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Therapeutic Proteins and Oral Vaccines Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Therapeutic Proteins and Oral Vaccines Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Therapeutic Proteins and Oral Vaccines Market Share by Region (2021-2026) Table 4. Global Therapeutic Proteins and Oral Vaccines Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Therapeutic Proteins and Oral Vaccines Market Share by Region (2027-2032) Table 6. Global Therapeutic Proteins and Oral Vaccines Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Therapeutic Proteins and Oral Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Therapeutic Proteins and Oral Vaccines Market Size Share by Type (2021-2026) Table 9. Global Therapeutic Proteins and Oral Vaccines Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Therapeutic Proteins and Oral Vaccines Market Size Share Forecasted by Type (2027-2032) Table 11. North America Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Therapeutic Proteins and Oral Vaccines Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Therapeutic Proteins and Oral Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Therapeutic Proteins and Oral Vaccines Market Size Share by Application (2021-2026) Table 24. Global Therapeutic Proteins and Oral Vaccines Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Therapeutic Proteins and Oral Vaccines Market Size Share Forecasted by Application (2027-2032) Table 26. North America Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Therapeutic Proteins and Oral Vaccines Industry Trends Table 37. Therapeutic Proteins and Oral Vaccines Industry Drivers Table 38. Therapeutic Proteins and Oral Vaccines Industry Opportunities and Challenges Table 39. Therapeutic Proteins and Oral Vaccines Industry Restraints Table 40. Global Therapeutic Proteins and Oral Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Company (2021-2026) Table 42. Global Therapeutic Proteins and Oral Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Therapeutic Proteins and Oral Vaccines Key Company Headquarters & Area Served Table 44. Global Therapeutic Proteins and Oral Vaccines Company, Product Type & Application Table 45. Global Therapeutic Proteins and Oral Vaccines Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Therapeutic Proteins and Oral Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Abbott Company Information Table 49. Abbott Business Overview Table 50. Abbott Therapeutic Proteins and Oral Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Abbott Therapeutic Proteins and Oral Vaccines Product Portfolio Table 52. Abbott Recent Development Table 53. Sanofi Company Information Table 54. Sanofi Business Overview Table 55. Sanofi Therapeutic Proteins and Oral Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Sanofi Therapeutic Proteins and Oral Vaccines Product Portfolio Table 57. Sanofi Recent Development Table 58. Merck Company Information Table 59. Merck Business Overview Table 60. Merck Therapeutic Proteins and Oral Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Merck Therapeutic Proteins and Oral Vaccines Product Portfolio Table 62. Merck Recent Development Table 63. Roche Company Information Table 64. Roche Business Overview Table 65. Roche Therapeutic Proteins and Oral Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Roche Therapeutic Proteins and Oral Vaccines Product Portfolio Table 67. Roche Recent Development Table 68. Pfizer Company Information Table 69. Pfizer Business Overview Table 70. Pfizer Therapeutic Proteins and Oral Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Pfizer Therapeutic Proteins and Oral Vaccines Product Portfolio Table 72. Pfizer Recent Development Table 73. Amgen Company Information Table 74. Amgen Business Overview Table 75. Amgen Therapeutic Proteins and Oral Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Amgen Therapeutic Proteins and Oral Vaccines Product Portfolio Table 77. Amgen Recent Development Table 78. TransAlgae Company Information Table 79. TransAlgae Business Overview Table 80. TransAlgae Therapeutic Proteins and Oral Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. TransAlgae Therapeutic Proteins and Oral Vaccines Product Portfolio Table 82. TransAlgae Recent Development Table 83. Serum Institute of India Company Information Table 84. Serum Institute of India Business Overview Table 85. Serum Institute of India Therapeutic Proteins and Oral Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Serum Institute of India Therapeutic Proteins and Oral Vaccines Product Portfolio Table 87. Serum Institute of India Recent Development Table 88. Novo Nordisk Company Information Table 89. Novo Nordisk Business Overview Table 90. Novo Nordisk Therapeutic Proteins and Oral Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Novo Nordisk Therapeutic Proteins and Oral Vaccines Product Portfolio Table 92. Novo Nordisk Recent Development Table 93. MigVax Company Information Table 94. MigVax Business Overview Table 95. MigVax Therapeutic Proteins and Oral Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. MigVax Therapeutic Proteins and Oral Vaccines Product Portfolio Table 97. MigVax Recent Development Table 98. Lumen Bioscience Company Information Table 99. Lumen Bioscience Business Overview Table 100. Lumen Bioscience Therapeutic Proteins and Oral Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Lumen Bioscience Therapeutic Proteins and Oral Vaccines Product Portfolio Table 102. Lumen Bioscience Recent Development Table 103. Johnson and Johnson Company Information Table 104. Johnson and Johnson Business Overview Table 105. Johnson and Johnson Therapeutic Proteins and Oral Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Johnson and Johnson Therapeutic Proteins and Oral Vaccines Product Portfolio Table 107. Johnson and Johnson Recent Development Table 108. Emergent Biosolutions Company Information Table 109. Emergent Biosolutions Business Overview Table 110. Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Product Portfolio Table 112. Emergent Biosolutions Recent Development Table 113. Eli Lilly and Company Company Information Table 114. Eli Lilly and Company Business Overview Table 115. Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Product Portfolio Table 117. Eli Lilly and Company Recent Development Table 118. Biogen Company Information Table 119. Biogen Business Overview Table 120. Biogen Therapeutic Proteins and Oral Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Biogen Therapeutic Proteins and Oral Vaccines Product Portfolio Table 122. Biogen Recent Development Table 123. North America Therapeutic Proteins and Oral Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Therapeutic Proteins and Oral Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Therapeutic Proteins and Oral Vaccines Market Share by Country (2021-2026) Table 126. North America Therapeutic Proteins and Oral Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Therapeutic Proteins and Oral Vaccines Market Share Forecast by Country (2027-2032) Table 128. Europe Therapeutic Proteins and Oral Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Therapeutic Proteins and Oral Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Therapeutic Proteins and Oral Vaccines Market Share by Country (2021-2026) Table 131. Europe Therapeutic Proteins and Oral Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Therapeutic Proteins and Oral Vaccines Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Share by Country (2021-2026) Table 136. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Share Forecast by Country (2027-2032) Table 138. Latin America Therapeutic Proteins and Oral Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Therapeutic Proteins and Oral Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Therapeutic Proteins and Oral Vaccines Market Share by Country (2021-2026) Table 141. Latin America Therapeutic Proteins and Oral Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Therapeutic Proteins and Oral Vaccines Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Share by Country (2021-2026) Table 146. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Therapeutic Proteins and Oral Vaccines Product Image Figure 3. Global Therapeutic Proteins and Oral Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Therapeutic Proteins and Oral Vaccines Market Size (2021-2032) & (US$ Million) Figure 5. Global Therapeutic Proteins and Oral Vaccines Market Share by Region: 2025 VS 2032 Figure 6. Global Therapeutic Proteins and Oral Vaccines Market Share by Region (2021-2032) Figure 7. North America Therapeutic Proteins and Oral Vaccines Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Therapeutic Proteins and Oral Vaccines Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Therapeutic Proteins and Oral Vaccines Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Therapeutic Proteins Image Figure 13. Global Therapeutic Proteins Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Oral Vaccines Image Figure 15. Global Oral Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Therapeutic Proteins and Oral Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Therapeutic Proteins and Oral Vaccines Market Share by Type 2025 VS 2032 Figure 18. North America Therapeutic Proteins and Oral Vaccines Market Size Share by Type (2021-2032) Figure 19. Europe Therapeutic Proteins and Oral Vaccines Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size Share by Type (2021-2032) Figure 21. Latin America Therapeutic Proteins and Oral Vaccines Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Therapeutic Proteins and Oral Vaccines Market Size Share by Type (2021-2032) Figure 23. Retail Pharmacies Image Figure 24. Global Retail Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Online Pharmacies Image Figure 26. Global Online Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Hospital Pharmacies Image Figure 28. Global Hospital Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Therapeutic Proteins and Oral Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Therapeutic Proteins and Oral Vaccines Market Share by Application 2025 VS 2032 Figure 31. North America Therapeutic Proteins and Oral Vaccines Market Size Share by Application (2021-2032) Figure 32. Europe Therapeutic Proteins and Oral Vaccines Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size Share by Application (2021-2032) Figure 34. Latin America Therapeutic Proteins and Oral Vaccines Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Therapeutic Proteins and Oral Vaccines Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Therapeutic Proteins and Oral Vaccines Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Therapeutic Proteins and Oral Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Therapeutic Proteins and Oral Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Therapeutic Proteins and Oral Vaccines Market Share by Country (2021-2032) Figure 41. Europe Therapeutic Proteins and Oral Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Therapeutic Proteins and Oral Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Therapeutic Proteins and Oral Vaccines Market Share by Country (2021-2032) Figure 44. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Share by Country (2021-2032) Figure 47. Latin America Therapeutic Proteins and Oral Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Therapeutic Proteins and Oral Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Therapeutic Proteins and Oral Vaccines Market Share by Country (2021-2032) Figure 50. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Therapeutic Proteins
  • Oral Vaccines
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Abbott
  • Sanofi
  • Merck
  • Roche
  • Pfizer
  • Amgen
  • TransAlgae
  • Serum Institute of India
  • Novo Nordisk
  • MigVax
  • Lumen Bioscience
  • Johnson and Johnson
  • Emergent Biosolutions
  • Eli Lilly and Company
  • Biogen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Therapeutic Proteins and Oral Vaccines Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Therapeutic Proteins and Oral Vaccines Market Size by Region (2021-2032)
  5. 1.4.1 Global Therapeutic Proteins and Oral Vaccines Market Size by Region (2021-2026)
  6. 1.4.2 Global Therapeutic Proteins and Oral Vaccines Market Size by Region (2027-2032)
  7. 1.5 Key Regions Therapeutic Proteins and Oral Vaccines Market Size (2021-2032)
  8. 1.5.1 North America Therapeutic Proteins and Oral Vaccines Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Therapeutic Proteins and Oral Vaccines Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Therapeutic Proteins and Oral Vaccines Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size Growth Rate (2021-2032)
2 Therapeutic Proteins and Oral Vaccines Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Therapeutic Proteins
  3. 2.1.2 Oral Vaccines
  4. 2.2 Global Therapeutic Proteins and Oral Vaccines Market Size by Type
  5. 2.2.1 Global Therapeutic Proteins and Oral Vaccines Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Therapeutic Proteins and Oral Vaccines Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Therapeutic Proteins and Oral Vaccines Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Therapeutic Proteins and Oral Vaccines Market Size by Regions
  9. 2.3.1 North America Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Type (2021-2026)
3 Therapeutic Proteins and Oral Vaccines Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Retail Pharmacies
  3. 3.1.2 Online Pharmacies
  4. 3.1.3 Hospital Pharmacies
  5. 3.2 Global Therapeutic Proteins and Oral Vaccines Market Size by Application
  6. 3.2.1 Global Therapeutic Proteins and Oral Vaccines Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Therapeutic Proteins and Oral Vaccines Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Therapeutic Proteins and Oral Vaccines Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Therapeutic Proteins and Oral Vaccines Market Size by Regions
  10. 3.3.1 North America Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Therapeutic Proteins and Oral Vaccines Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Therapeutic Proteins and Oral Vaccines Industry Trends
  2. 4.2 Therapeutic Proteins and Oral Vaccines Industry Drivers
  3. 4.3 Therapeutic Proteins and Oral Vaccines Industry Opportunities and Challenges
  4. 4.4 Therapeutic Proteins and Oral Vaccines Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Therapeutic Proteins and Oral Vaccines Revenue (2021-2026)
  2. 5.2 Global Therapeutic Proteins and Oral Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Therapeutic Proteins and Oral Vaccines Key Company Headquarters & Area Served
  4. 5.4 Global Therapeutic Proteins and Oral Vaccines Company, Product Type & Application
  5. 5.5 Global Therapeutic Proteins and Oral Vaccines Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Therapeutic Proteins and Oral Vaccines Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Therapeutic Proteins and Oral Vaccines Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Therapeutic Proteins and Oral Vaccines Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Therapeutic Proteins and Oral Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Therapeutic Proteins and Oral Vaccines Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Therapeutic Proteins and Oral Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Therapeutic Proteins and Oral Vaccines Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Therapeutic Proteins and Oral Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Merck Therapeutic Proteins and Oral Vaccines Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Roche
  20. 6.4.1 Roche Company Information
  21. 6.4.2 Roche Business Overview
  22. 6.4.3 Roche Therapeutic Proteins and Oral Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Roche Therapeutic Proteins and Oral Vaccines Product Portfolio
  24. 6.4.5 Roche Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Therapeutic Proteins and Oral Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Therapeutic Proteins and Oral Vaccines Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Amgen
  32. 6.6.1 Amgen Company Information
  33. 6.6.2 Amgen Business Overview
  34. 6.6.3 Amgen Therapeutic Proteins and Oral Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Amgen Therapeutic Proteins and Oral Vaccines Product Portfolio
  36. 6.6.5 Amgen Recent Developments
  37. 6.7 TransAlgae
  38. 6.7.1 TransAlgae Company Information
  39. 6.7.2 TransAlgae Business Overview
  40. 6.7.3 TransAlgae Therapeutic Proteins and Oral Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 TransAlgae Therapeutic Proteins and Oral Vaccines Product Portfolio
  42. 6.7.5 TransAlgae Recent Developments
  43. 6.8 Serum Institute of India
  44. 6.8.1 Serum Institute of India Company Information
  45. 6.8.2 Serum Institute of India Business Overview
  46. 6.8.3 Serum Institute of India Therapeutic Proteins and Oral Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Serum Institute of India Therapeutic Proteins and Oral Vaccines Product Portfolio
  48. 6.8.5 Serum Institute of India Recent Developments
  49. 6.9 Novo Nordisk
  50. 6.9.1 Novo Nordisk Company Information
  51. 6.9.2 Novo Nordisk Business Overview
  52. 6.9.3 Novo Nordisk Therapeutic Proteins and Oral Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Novo Nordisk Therapeutic Proteins and Oral Vaccines Product Portfolio
  54. 6.9.5 Novo Nordisk Recent Developments
  55. 6.10 MigVax
  56. 6.10.1 MigVax Company Information
  57. 6.10.2 MigVax Business Overview
  58. 6.10.3 MigVax Therapeutic Proteins and Oral Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 MigVax Therapeutic Proteins and Oral Vaccines Product Portfolio
  60. 6.10.5 MigVax Recent Developments
  61. 6.11 Lumen Bioscience
  62. 6.11.1 Lumen Bioscience Company Information
  63. 6.11.2 Lumen Bioscience Business Overview
  64. 6.11.3 Lumen Bioscience Therapeutic Proteins and Oral Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Lumen Bioscience Therapeutic Proteins and Oral Vaccines Product Portfolio
  66. 6.11.5 Lumen Bioscience Recent Developments
  67. 6.12 Johnson and Johnson
  68. 6.12.1 Johnson and Johnson Company Information
  69. 6.12.2 Johnson and Johnson Business Overview
  70. 6.12.3 Johnson and Johnson Therapeutic Proteins and Oral Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Johnson and Johnson Therapeutic Proteins and Oral Vaccines Product Portfolio
  72. 6.12.5 Johnson and Johnson Recent Developments
  73. 6.13 Emergent Biosolutions
  74. 6.13.1 Emergent Biosolutions Company Information
  75. 6.13.2 Emergent Biosolutions Business Overview
  76. 6.13.3 Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Product Portfolio
  78. 6.13.5 Emergent Biosolutions Recent Developments
  79. 6.14 Eli Lilly and Company
  80. 6.14.1 Eli Lilly and Company Company Information
  81. 6.14.2 Eli Lilly and Company Business Overview
  82. 6.14.3 Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Product Portfolio
  84. 6.14.5 Eli Lilly and Company Recent Developments
  85. 6.15 Biogen
  86. 6.15.1 Biogen Company Information
  87. 6.15.2 Biogen Business Overview
  88. 6.15.3 Biogen Therapeutic Proteins and Oral Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Biogen Therapeutic Proteins and Oral Vaccines Product Portfolio
  90. 6.15.5 Biogen Recent Developments
7 North America
  1. 7.1 North America Therapeutic Proteins and Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Therapeutic Proteins and Oral Vaccines Market Size by Country (2021-2026)
  3. 7.3 North America Therapeutic Proteins and Oral Vaccines Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Therapeutic Proteins and Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Therapeutic Proteins and Oral Vaccines Market Size by Country (2021-2026)
  3. 8.3 Europe Therapeutic Proteins and Oral Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Therapeutic Proteins and Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Therapeutic Proteins and Oral Vaccines Market Size by Country (2021-2026)
  3. 10.3 South America Therapeutic Proteins and Oral Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst